Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
P ScheltensAlexander Kurz

Abstract

To investigate the effect of a medical food on cognitive function in people with mild Alzheimer's disease (AD). A total of 225 drug-naïve AD patients participated in this randomized, double-blind controlled trial. Patients were randomized to active product, Souvenaid, or a control drink, taken once-daily for 12 weeks. Primary outcome measures were the delayed verbal recall task of the Wechsler Memory Scale-revised, and the 13-item modified Alzheimer's Disease Assessment Scale-cognitive subscale at week 12. At 12 weeks, significant improvement in the delayed verbal recall task was noted in the active group compared with control (P = .021). Modified Alzheimer's Disease Assessment Scale-cognitive subscale and other outcome scores (e.g., Clinician Interview Based Impression of Change plus Caregiver Input, 12-item Neuropsychiatric Inventory, Alzheimer's disease Co-operative Study-Activities of Daily Living, Quality of Life in Alzheimer's Disease) were unchanged. The control group neither deteriorated nor improved. Compliance was excellent (95%) and the product was well tolerated. Supplementation with a medical food including phosphatide precursors and cofactors for 12 weeks improved memory (delayed verbal recall) in mild AD patients...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Jan 1, 1982·Journal of Psychiatric Research·J A YesavageV O Leirer
May 1, 1996·Archives of Neurology·P A SpiersR J Wurtman
Dec 26, 2001·Nature Reviews. Neuroscience·H Hering, M Sheng
Oct 26, 2002·Science·Dennis J Selkoe
May 10, 2003·Neurobiology of Learning and Memory·N M W J De BruinL M Broersen
Sep 24, 2004·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Paul F BostonCrispin N Bennett
Aug 2, 2006·Journal of Geriatric Psychiatry and Neurology·Robert D Terry
Dec 15, 2006·Lancet Neurology·Bruno VellasUNKNOWN European Task Force group
Jan 24, 2007·Neuroscience·J I ArellanoJ DeFelipe
May 9, 2007·Nature Neuroscience·Nicolas ToniFred H Gage
Apr 1, 2008·European Journal of Pharmacology·Eline M van der Beek, Patrick J G H Kamphuis
Jul 9, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Sarah HolguinRichard Wurtman
Jul 22, 2008·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Mehmet CansevIsmail H Ulus
Sep 16, 2009·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Lon S Schneider, Mary Sano

❮ Previous
Next ❯

Citations

May 4, 2010·Molecular Neurobiology·Sally A Frautschy, Greg M Cole
Feb 18, 2011·The Journal of Biological Chemistry·Marcus O W GrimmTobias Hartmann
Mar 7, 2012·Cold Spring Harbor Perspectives in Medicine·Paul S AisenLon S Schneider
Jan 24, 2013·Dementia and Geriatric Cognitive Disorders Extra·Willem J R BossersMarieke J G van Heuvelen
Feb 26, 2010·The Journal of Nutrition·Greg M Cole, Sally A Frautschy
Jan 31, 2013·Clinical Practice·Papan Thaipisuttikul, James E Galvin
Sep 14, 2012·Neurodegenerative Disease Management·James E Galvin
Jul 31, 2013·European Journal of Nutrition·Ane Otaegui-ArrazolaPablo Martínez-Lage
Mar 15, 2014·The Journal of Nutrition, Health & Aging·C W RitchieP Passmore
Feb 28, 2014·BioMed Research International·Marcus O W GrimmTobias Hartmann
Jul 19, 2013·BioMed Research International·Nan HuLan Tan
Jun 6, 2014·Neural Plasticity·Tytus MurphySandrine Thuret
Dec 1, 2010·Nutrition Reviews·Greg M ColeSally A Frautschy
Jan 24, 2013·International Journal of Nursing Studies·Wen LiuSue A Thomas
Apr 2, 2016·Neural Plasticity·Maximilian WiesmannAmanda J Kiliaan
Mar 19, 2014·Acta Clinica Belgica·S EngelborghsM Vandewoude
Jul 17, 2015·Oxidative Medicine and Cellular Longevity·Mika ReinisaloReijo O Karjalainen
May 23, 2015·Metallomics : Integrated Biometal Science·Bárbara Rita CardosoDominic J Hare
Aug 18, 2016·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Jan AasethUrban Alehagen
Aug 26, 2014·Neurobiology of Aging·Mehmet CansevLaus M Broersen
Jan 24, 2017·International Journal of Biological Macromolecules·Badar Ul Islam, Shams Tabrez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

Epidemiology of Aging

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Aging Epidemiology

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

Brain developing: Influences & Outcomes

This feed focuses on influences that affect the developing brain including genetics, fetal development, prenatal care, and gene-environment interactions. Here is the latest research in this field.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.